212 related articles for article (PubMed ID: 18367125)
1. Tissue-marking scheme for a cost-effective extended prostate biopsy protocol.
Firoozi F; Nazeer T; Fisher HA; Kaufman RP; White MD; Mian BM
Urol Oncol; 2009; 27(1):21-5. PubMed ID: 18367125
[TBL] [Abstract][Full Text] [Related]
2. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.
Taneja SS; Penson DF; Epelbaum A; Handler T; Lepor H
J Urol; 1999 Oct; 162(4):1352-7; discussion 1357-8. PubMed ID: 10492195
[TBL] [Abstract][Full Text] [Related]
3. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer.
Elliott SP; Shinohara K; Logan SL; Carroll PR
J Urol; 2002 Jul; 168(1):105-9. PubMed ID: 12050501
[TBL] [Abstract][Full Text] [Related]
4. Prediction of extracapsular extension of prostate cancer based on systematic core biopsies.
Tarján M; Tot T
Scand J Urol Nephrol; 2006; 40(6):459-64. PubMed ID: 17130097
[TBL] [Abstract][Full Text] [Related]
5. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H
J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
[TBL] [Abstract][Full Text] [Related]
6. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
7. Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score?
Kunju LP; Daignault S; Wei JT; Shah RB
Hum Pathol; 2009 Apr; 40(4):558-64. PubMed ID: 19144380
[TBL] [Abstract][Full Text] [Related]
8. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.
Singh H; Canto EI; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM
J Urol; 2004 Jan; 171(1):204-9. PubMed ID: 14665877
[TBL] [Abstract][Full Text] [Related]
9. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.
Scattoni V; Raber M; Abdollah F; Roscigno M; Dehò F; Angiolilli D; Maccagnano C; Gallina A; Capitanio U; Freschi M; Doglioni C; Rigatti P; Montorsi F
Eur Urol; 2010 Jan; 57(1):1-8. PubMed ID: 19720449
[TBL] [Abstract][Full Text] [Related]
10. Role of prostate biopsy schemes in accurate prediction of Gleason scores.
Mian BM; Lehr DJ; Moore CK; Fisher HA; Kaufman RP; Ross JS; Jennings TA; Nazeer T
Urology; 2006 Feb; 67(2):379-83. PubMed ID: 16461089
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cancers detected at only a sextant or alternative location.
Ochiai A; Troncoso P; Babaian RJ
BJU Int; 2008 Apr; 101(7):837-40. PubMed ID: 18070187
[TBL] [Abstract][Full Text] [Related]
12. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
Sankin A; Tareen B; Lepor H
Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170
[TBL] [Abstract][Full Text] [Related]
13. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
Campos-Fernandes JL; Bastien L; Nicolaiew N; Robert G; Terry S; Vacherot F; Salomon L; Allory Y; Vordos D; Hoznek A; Yiou R; Patard JJ; Abbou CC; de la Taille A
Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
[TBL] [Abstract][Full Text] [Related]
15. Extended biopsy protocol decreases prostate cancer incidence and risk of aggressive disease on repeated biopsies compared with initial standard procedure.
Ploussard G; Bastien L; Descazeaud A; Robert G; Allory Y; Salomon L; Vordos D; Hoznek A; Yiou R; Abbou CC; de la Taille A
Urol Int; 2010; 84(2):147-52. PubMed ID: 20215817
[TBL] [Abstract][Full Text] [Related]
16. [Prostate biopsies: how many samples and how many containers? Cost effectiveness].
Molinié V; Mahjoub WK; Balaton A
Ann Pathol; 2008 Oct; 28(5):424-8. PubMed ID: 19068397
[TBL] [Abstract][Full Text] [Related]
17. Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland.
Matsumoto K; Egawa S; Satoh T; Kuruma H; Yanagisawa N; Baba S
Int J Urol; 2006 Oct; 13(10):1290-5. PubMed ID: 17010007
[TBL] [Abstract][Full Text] [Related]
18. A clinicopathologic study of preoperative and postoperative findings with minute Gleason 3+3=6 cancer at radical prostatectomy.
Osunkoya AO; Carter HB; Epstein JI
Urology; 2008 Sep; 72(3):638-40. PubMed ID: 18400278
[TBL] [Abstract][Full Text] [Related]
19. The 20-core prostate biopsy protocol--a new gold standard?
Ravery V; Dominique S; Panhard X; Toublanc M; Boccon-Gibod L; Boccon-Gibod L
J Urol; 2008 Feb; 179(2):504-7. PubMed ID: 18076947
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
